Insiders Updates Analysts: TSHA stock price target of 8.5 in 12 months Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Stock Earnings TSHA stock rated an Outperform by BMO Capital Markets Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Analysts Viewpoint Days-to-cover ratio for TSHA surges to 6.29 due to rise in short interest Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Taysha Gene Therapies Inc [TSHA] Investment Guide: What You Need to Know In a filing, Taysha Gene Therapies Inc revealed its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06